Home > Healthcare > Medical Devices > Diagnostic Devices > STD Diagnostics Market

STD Diagnostics Market Share

Report ID: GMI8292
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

STD Diagnostics Market Share

The STD diagnostics industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Abbott Laboratories, Thermo Fisher Scientific, Becton, Dickinson, and Company among others have a notable presence in the market.

STD Diagnostics Market Companies

Some of the eminent market participants operating in the STD diagnostics industry include:

Abbott Laboratories
Becton, Dickinson, and Company
bioMerieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
QIAGEN N.V.
Seegene Inc.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Trinity Biotech plc

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of STD diagnostics reached USD 13.8 billion in 2023 and is set to cross USD 25.7 billion by 2032, owing to the rising prevalence of sexually transmitted diseases, and a growing need for effective management & treatment options.

The consumables segment is estimated to surpass USD 18.3 billion by 2032, due to their ability to comprehensive management of STDs by facilitating accurate diagnosis, prompt treatment initiation, preventive measures, and patient education.

North America market accounted for USD 5.6 billion in 2023, backed by a sophisticated healthcare infrastructure, rising prevalence of STDs, rapid technological advancement, and substantial healthcare spending in the region.

Abbott Laboratories, Becton, Dickinson, and Company, bioM